A detailed history of Royal Bank Of Canada transactions in Eli Lilly & CO stock. As of the latest transaction made, Royal Bank Of Canada holds 2,554,405 shares of LLY stock, worth $2.03 Billion. This represents 0.48% of its overall portfolio holdings.

Number of Shares
2,554,405
Previous 2,410,160 5.98%
Holding current value
$2.03 Billion
Previous $2.18 Billion 3.71%
% of portfolio
0.48%
Previous 0.52%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $111 Million - $138 Million
144,245 Added 5.98%
2,554,405 $2.26 Billion
Q2 2024

Nov 06, 2024

SELL
$724.87 - $909.04 $25.5 Million - $32 Million
-35,242 Reduced 1.44%
2,410,160 $2.18 Billion
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $57.1 Million - $71.6 Million
78,759 Added 3.33%
2,445,402 $2.21 Billion
Q1 2024

Nov 05, 2024

SELL
$592.2 - $792.28 $66.8 Million - $89.4 Million
-112,835 Reduced 4.61%
2,332,567 $1.81 Billion
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $8.99 Million - $12 Million
15,175 Added 0.65%
2,366,643 $1.84 Billion
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $69.5 Million - $82 Million
132,425 Added 5.97%
2,351,468 $1.37 Billion
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $62.7 Million - $86.5 Million
-144,310 Reduced 6.11%
2,219,043 $1.19 Billion
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $26.2 Million - $35 Million
74,649 Added 3.26%
2,363,353 $1.11 Billion
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $59.1 Million - $69.4 Million
-190,252 Reduced 7.67%
2,288,704 $786 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $39.1 Million - $45.5 Million
121,452 Added 5.15%
2,478,956 $907 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $14.2 Million - $16.2 Million
47,923 Added 2.07%
2,357,504 $762 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $6.92 Million - $8.12 Million
24,818 Added 1.09%
2,309,581 $749 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $34.4 Million - $42.7 Million
-146,497 Reduced 6.03%
2,284,763 $654 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $3.85 Million - $4.77 Million
17,106 Added 0.71%
2,431,260 $672 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $8.94 Million - $11 Million
-40,358 Reduced 1.64%
2,414,154 $558 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $443 Million - $573 Million
2,454,512 New
2,454,512 $563 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.